Literature DB >> 25171458

The metabolic syndrome and cognitive decline in the Atherosclerosis Risk in Communities study (ARIC).

Jennifer L Dearborn1, David Knopman, A Richey Sharrett, Andrea L C Schneider, Clifford R Jack, Laura H Coker, Alvaro Alonso, Elizabeth Selvin, Thomas H Mosley, Lynne E Wagenknecht, Beverly G Windham, Rebecca F Gottesman.   

Abstract

BACKGROUND: Midlife metabolic syndrome (MetS) may impact cognitive health as a construct independently of hypertension, hyperlipidemia and other components.
METHODS: 10,866 participants aged 45-64 years at baseline were assessed for MetS and completed cognitive testing at two later time points (3 and 9 years from the baseline visit).
RESULTS: MetS is associated with increased odds of low cognitive performance in the domains of executive function and word fluency, but not with 6-year cognitive decline. Individual MetS components explained this association (hypertension, diabetes, low HDL, elevated triglycerides and increased waist circumference).
CONCLUSIONS: A focus on the individual risk factors as opposed to MetS during midlife is important to reduce the incidence of cognitive impairment in later life.

Entities:  

Mesh:

Year:  2014        PMID: 25171458      PMCID: PMC4201882          DOI: 10.1159/000362265

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  33 in total

Review 1.  Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies.

Authors:  Apoor S Gami; Brandi J Witt; Daniel E Howard; Patricia J Erwin; Lisa A Gami; Virend K Somers; Victor M Montori
Journal:  J Am Coll Cardiol       Date:  2007-01-12       Impact factor: 24.094

2.  Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study.

Authors:  Philip A Wolf; Alexa Beiser; Merrill F Elias; Rhoda Au; Ramachandran S Vasan; Sudha Seshadri
Journal:  Curr Alzheimer Res       Date:  2007-04       Impact factor: 3.498

Review 3.  Fat as an endocrine organ: relationship to the metabolic syndrome.

Authors:  Louise Hutley; Johannes B Prins
Journal:  Am J Med Sci       Date:  2005-12       Impact factor: 2.378

4.  Obesity, diabetes and cognitive deficit: The Framingham Heart Study.

Authors:  Merrill F Elias; Penelope K Elias; Lisa M Sullivan; Philip A Wolf; Ralph B D'Agostino
Journal:  Neurobiol Aging       Date:  2005-10-11       Impact factor: 4.673

5.  Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.

Authors:  Wolfgang Lieb; Alexa S Beiser; Ramachandran S Vasan; Zaldy S Tan; Rhoda Au; Tamara B Harris; Ronenn Roubenoff; Sanford Auerbach; Charles DeCarli; Philip A Wolf; Sudha Seshadri
Journal:  JAMA       Date:  2009-12-16       Impact factor: 56.272

6.  Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.

Authors:  David S Knopman; Thomas H Mosley; Diane J Catellier; Laura H Coker
Journal:  Alzheimers Dement       Date:  2009-04-11       Impact factor: 21.566

7.  Metabolic syndrome and dementia risk in a multiethnic elderly cohort.

Authors:  Majon Muller; Ming-Xin Tang; Nicole Schupf; Jennifer J Manly; Richard Mayeux; José A Luchsinger
Journal:  Dement Geriatr Cogn Disord       Date:  2007-07-18       Impact factor: 2.959

8.  Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men.

Authors:  Tobias Pischon; Frank B Hu; Kathryn M Rexrode; Cynthia J Girman; Joann E Manson; Eric B Rimm
Journal:  Atherosclerosis       Date:  2007-08-02       Impact factor: 5.162

Review 9.  Risk of dementia in diabetes mellitus: a systematic review.

Authors:  Geert Jan Biessels; Salka Staekenborg; Eric Brunner; Carol Brayne; Philip Scheltens
Journal:  Lancet Neurol       Date:  2006-01       Impact factor: 44.182

10.  Magnetic resonance imaging predictors of cognition in mild cognitive impairment.

Authors:  Laura A van de Pol; Esther S C Korf; Wiesje M van der Flier; H Robert Brashear; Nick C Fox; Frederik Barkhof; Philip Scheltens
Journal:  Arch Neurol       Date:  2007-07
View more
  15 in total

Review 1.  Microvascular perfusion heterogeneity contributes to peripheral vascular disease in metabolic syndrome.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Stephanie J Frisbee; Joshua T Butcher; Fan Wu; Paul D Chantler
Journal:  J Physiol       Date:  2014-12-18       Impact factor: 5.182

Review 2.  Metabolic, inflammatory, and microvascular determinants of white matter disease and cognitive decline.

Authors:  Maggie Wang; Jennifer E Norman; Vivek J Srinivasan; John C Rutledge
Journal:  Am J Neurodegener Dis       Date:  2016-11-30

3.  Increased pulse wave velocity is related to impaired working memory and executive function in older adults with metabolic syndrome.

Authors:  Jigar Gosalia; Polly S Montgomery; Shangming Zhang; William A Pomilla; Ming Wang; Menglu Liang; Anna Csiszar; Zoltan Ungvari; Andriy Yabluchanskiy; David N Proctor; Andrew W Gardner
Journal:  Geroscience       Date:  2022-08-18       Impact factor: 7.581

4.  Waist circumference is correlated with poorer cognition in elderly type 2 diabetes women.

Authors:  Rebecca K West; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Derek Leroith; Keren Koifman; Ryan C N D'Arcy; Xiaowei Song; Elizabeth Guerrero-Berroa; Rachel Preiss; Hadas Hoffman; Mary Sano; Jeremy M Silverman; Michal Schnaider-Beeri
Journal:  Alzheimers Dement       Date:  2016-05-02       Impact factor: 21.566

5.  Personality Correlates of Midlife Cardiometabolic Risk: The Explanatory Role of Higher-Order Factors of the Five-Factor Model.

Authors:  Sarah S Dermody; Aidan G C Wright; JeeWon Cheong; Karissa G Miller; Matthew F Muldoon; Janine D Flory; Peter J Gianaros; Anna L Marsland; Stephen B Manuck
Journal:  J Pers       Date:  2015-09-04

6.  Obesity, Insulin Resistance, and Incident Small Vessel Disease on Magnetic Resonance Imaging: Atherosclerosis Risk in Communities Study.

Authors:  Jennifer L Dearborn; Andrea L C Schneider; A Richey Sharrett; Thomas H Mosley; Daniel C Bezerra; David S Knopman; Elizabeth Selvin; Clifford R Jack; Laura H Coker; Alvaro Alonso; Lynne E Wagenknecht; Beverly G Windham; Rebecca F Gottesman
Journal:  Stroke       Date:  2015-10-08       Impact factor: 7.914

7.  Is Midlife Metabolic Syndrome Associated With Cognitive Function Change? The Study of Women's Health Across the Nation.

Authors:  Rasa Kazlauskaite; Imke Janssen; Robert S Wilson; Bradley M Appelhans; Denis A Evans; Zoe Arvanitakis; Samar R El Khoudary; Howard M Kravitz
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

8.  Abdominal obesity is a risk factor for dysexecutive function in chronic kidney disease.

Authors:  Andrea R Zammit; Mindy J Katz; Carol Derby; Markus Bitzer; Richard B Lipton
Journal:  Prev Med Rep       Date:  2016-06-07

9.  Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease.

Authors:  Naveed Malek; Michael A Lawton; Diane M A Swallow; Katherine A Grosset; Sarah L Marrinan; Nin Bajaj; Roger A Barker; David J Burn; John Hardy; Huw R Morris; Nigel M Williams; Nicholas Wood; Yoav Ben-Shlomo; Donald G Grosset
Journal:  Mov Disord       Date:  2016-10       Impact factor: 10.338

10.  Association of parathyroid hormone with 20-year cognitive decline: The ARIC study.

Authors:  Samuel M Kim; Di Zhao; Andrea L C Schneider; Sai Krishna Korada; Pamela L Lutsey; Eliseo Guallar; Alvaro Alonso; B Gwen Windham; Rebecca F Gottesman; Erin D Michos
Journal:  Neurology       Date:  2017-08-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.